Related Experiment Videos
Does piracetam counteract the ECT-induced memory dysfunctions in depressed patients?
Acta Psychiatrica Scandinavica
|June 1, 1975
Summary
This study found piracetam did not improve memory in patients undergoing electroconvulsive therapy (ECT). Further research is needed on piracetam
Area of Science:
- Neuroscience
- Psychopharmacology
Background:
- Electroconvulsive therapy (ECT) can cause memory impairment.
- Piracetam is a nootropic agent with potential neuroprotective effects.
Purpose of the Study:
- To investigate the efficacy of piracetam in mitigating retrograde memory impairment following ECT.
- To assess piracetam's impact on seizure duration, EEG patterns, and post-ECT confusion.
Main Methods:
- Double-blind, intra-individual cross-over study.
- 18 patients with depression undergoing second and third Bi-ECT.
- Piracetam administered orally (4.8 g/day for 3 days).
- Memory assessed using the KS memory test battery.
Main Results:
- No significant improvements in memory scores were observed.
- Piracetam did not significantly alter seizure duration, EEG patterns, or post-ECT confusion time.
- Findings suggest piracetam's protective effects in animal models may relate to counteracting hypoxia.
Conclusions:
- Piracetam demonstrated no significant benefit for ECT-induced memory impairment in this patient group.
- Further investigation into piracetam's pharmacokinetics and mechanism of action is warranted.
- Potential role of piracetam in mitigating hypoxia-related memory deficits requires more study.